Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA)

Mycopathologia

Volumn 164, Issue 6, 2007, Pages 301-306

  Ramage, Gordon ^a   Wickes, Brian L ^b   López Ribot, José L ^c  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Biofilm; Candida albicans; EDTA

Indexed keywords

CHELATING AGENT; EDETIC ACID; FUNGAL PROTEIN; HWP1 PROTEIN, CANDIDA ALBICANS; MEMBRANE PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CHEMISTRY; CROSS INFECTION; DRUG EFFECT; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; NORTHERN BLOTTING; PHYSIOLOGY;

BIOFILMS; BLOTTING, NORTHERN; CANDIDA ALBICANS; CHELATING AGENTS; CROSS INFECTION; EDETIC ACID; FUNGAL PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; RNA;

CANDIDA ALBICANS;

EID: 35448933664     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-007-9068-x     Document Type: Article

References (30)

1. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167:1247-51.
2. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002;21:767-74.
3. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004;17:255-67.
4. Nikawa H, Nishimura H, Hamada T, Kumagai H, Samaranayake LP. Effects of dietary sugars and, saliva and serum on Candida bioflim formation on acrylic surfaces. Mycopathologia 1997;139:87-91.
5. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006;6:979-86.
6. Jin Y, Zhang T, Samaranayake YH, Fang HH, Yip HK, Samaranayake LP. The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 2005;159:353-60.
7. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005;4:633-8.
8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
9. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001;33:1387-92.
10. Berman J, Sudbery PE. Candida Albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 2002;3:918-30.
11. He M, Du M, Fan M, Bian Z. In vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 2007; 163(3):137-43.
12. Lopez-Ribot JL. Candida albicans biofilms: more than filamentation. Curr Biol 2005;15:R453-5.
13. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006;9:340-5.
14. Nobile CJ, Mitchell AP. Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol 2006;8: 1382-91.
15. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 1999;48:671-9.
16. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006;2:e63.
17. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 2002;214:95-100.
18. Nobile CJ, Mitchell AP. C. albicans transcription factor Bcr1p: a regulator of cell-surface genes and biofilm formation. Curr Biol 2005;15:1150-5.
19. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006;5:1604-10.
20. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 2002; 68:5459-63.
21. Gil ML, Casanova M, Martinez JP. Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch Microbiol 1994;161:489-94.
22. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005;26:515-9.
23. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 2003;47:3580-5.
24. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001;45:2475-9.
25. Ramage G, VandeWalle K, Wickes BL, Lopez-Ribot JL. Characteristics of Biofilm Formation by Candida albicans. Rev Iberoam Micol 2001;18:163-70.
26. Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002;49:973-80.
27. Staab JF, Sundstrom P. Genetic organization and sequence analysis of the hypha-specific cell wall protein gene HWP1 of Candida albicans. Yeast 1998;14:681-6.
28. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003;2:1053-60.
29. Turakhia MH, Cooksey KE, Characklis WG. Influence of a calcium-specific chelant on biofilm removal. Appl Environ Microbiol 1983;46:1236-8.
30. Harrison JJ, Turner RJ, Ceri H. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents. FEMS Microbiol Lett 2007;272:172-81.